FindTrial
Sign In

R279741

2 trials

Sponsors

Pharma Mar SA Unipersonal, Pharma Mar, S.A.

Conditions

Advanced or Metastatic Liposarcoma or Leiomyosarcoma MedDRA version: 5.0 Level: PT Classification code 10039494Localized myxoid / round cell liposarcoma previously untreated with chemotherapy or radiation MedDRA version: 9.1 Level: LLT Classification code 10024630 Term: Liposarcoma non-metastatic

Phase 2

A Randomized, Multicenter, Open-label Study of YONDELIS ™ (ET-743 ecteinascidin) Administered by 2 Different Schedules (Weekly for 3 of 4 weeks vs. q3 Weeks) in Subjects With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma Following Treatment With an Anthracycline and Ifosfamide - N/A
Active, not recruitingEUCTR2004-002106-29-GB
Pharma Mar SA UnipersonalAdvanced or Metastatic Liposarcoma or Leiomyosarcoma MedDRA version: 5.0 Level: PT Classification code 10039494
Start: 2005-05-13Target: 260Updated: 2020-07-27
A Multicenter Phase II Clinical Trial of Neoadjuvant Trabectedin (Yondelis®) in Patients with Localized Myxoid / Round Cell Liposarcoma
Active, not recruitingEUCTR2007-000035-25-FR
Pharma Mar, S.A.Localized myxoid / round cell liposarcoma previously untreated with chemotherapy or radiation MedDRA version: 9.1 Level: LLT Classification code 10024630 Term: Liposarcoma non-metastatic
Start: 2007-07-13Target: 22Updated: 2021-10-08